Fam-Trastuzumab Deruxtecan in Recurrent Low-Grade Serous Ovarian Carcinoma With CLU/NRG1 Fusion and Low Human Epidermal Growth Factor Receptor 2 Expression: A Case Report
JCO Precision Oncology · 2026-08 · 10 (8)
DOI: 10.1200/po-26-00288 ↗Kurz gefasst
Fallbericht in der Zeitschrift JCO Precision Oncology, 2026-08. Verfasst von Aimee Keegan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ambulatory Pharmacy, City of Hope Comprehensive Cancer Center, Duarte, CA. Die Arbeit nennt 20 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Ambulatory Pharmacy, City of Hope Comprehensive Cancer Center, Duarte, CA.
- Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center and Beckman Research Institute, Duarte, CA.
- Department of Pathology, Beckman Research Institute, City of Hope Comprehensive Cancer Center, Duarte, CA.
- Department of Surgery, Beckman Research Institute, City of Hope Comprehensive Cancer Center, Duarte, CA.
ORCID-Profile: Aimee Keegan, Fang Fan, Emily Engelkemier, Thanh Dellinger, Edward Wenge Wang
Zitieren
APA
Keegan, A., Yue, E., Fan, F., Engelkemier, E., Dellinger, T., & Wang, E. W. (2026). Fam-Trastuzumab Deruxtecan in Recurrent Low-Grade Serous Ovarian Carcinoma With CLU/NRG1 Fusion and Low Human Epidermal Growth Factor Receptor 2 Expression: A Case Report. JCO Precision Oncology, 10(8). https://doi.org/10.1200/po-26-00288
Vancouver
Keegan A, Yue E, Fan F, Engelkemier E, Dellinger T, Wang EW. Fam-Trastuzumab Deruxtecan in Recurrent Low-Grade Serous Ovarian Carcinoma With CLU/NRG1 Fusion and Low Human Epidermal Growth Factor Receptor 2 Expression: A Case Report. JCO Precision Oncology. 2026;10(8). doi:10.1200/po-26-00288
BibTeX
@article{Keegan2026,
author = {Keegan, Aimee and Yue, Er and Fan, Fang and Engelkemier, Emily and Dellinger, Thanh and Wang, Edward Wenge},
title = {Fam-Trastuzumab Deruxtecan in Recurrent Low-Grade Serous Ovarian Carcinoma With CLU/NRG1 Fusion and Low Human Epidermal Growth Factor Receptor 2 Expression: A Case Report},
journal = {JCO Precision Oncology},
year = {2026},
volume = {10},
number = {8},
doi = {10.1200/po-26-00288}
}
EUVIMED